The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease
is scheduled for release on December 10, 2025. This latest update to the "definitive reference" in gastroenterology is guided by a new senior editorial team consisting of Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox. Key New Features & Updates
Modern Clinical Topics: The new edition introduces specific chapters on Gastrointestinal and Hepatic Manifestations of Coronavirus Infection and Enterocolitis and Hepatitis Induced by Cancer Immunotherapy.
Advanced Diagnostics: It features expanded discussions on the use of Artificial Intelligence (AI) in endoscopy to improve the detection of GI cancers.
Renamed & Expanded Liver Coverage: In line with updated medical terminology, the text now covers MASLD (metabolic dysfunction-associated steatotic liver disease), formerly known as non-alcoholic fatty liver disease (NAFLD).
Therapeutic Advances: Includes updated information on biologic agents and novel small molecules for Inflammatory Bowel Disease (IBD) and new treatments for viral hepatitis and autoimmune liver diseases.
Procedural Content: The companion eBook includes over 20 procedural videos covering endoscopic techniques like balloon dilatation and stent placement.
Visual & Reference Tools: Over 1,100 full-color illustrations and new quick-reference algorithms are designed to aid in rapid clinical decision-making. Ordering Information
You can find the 12th edition for pre-order or purchase at major retailers and educational platforms: Physical 2-Volume Set: Available at Elsevier and Amazon.
Digital Edition: Available via VitalSource and as an eBook on Barnes & Noble.
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
12th edition Sleisenger and Fordtran's Gastrointestinal and Liver Disease released in December 2025
. This updated two-volume masterwork continues its 50-year legacy as the definitive reference for gastroenterology and hepatology. Key Updates in the 12th Edition
The latest edition introduces critical new content and a fresh senior editorial team led by Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox New Chapters : Covers contemporary clinical challenges including the
Gastrointestinal and Hepatic Manifestations of Coronavirus Infection Enterocolitis and Hepatitis Induced by Cancer Immunotherapy AI and Technology : Features new discussions on using Artificial Intelligence (AI) in endoscopy to improve the detection of GI cancers. Updated Terminology & Conditions : Includes expanded coverage of
(Metabolic dysfunction-associated steatotic liver disease, formerly NAFLD) and eosinophilic disorders Advanced Treatments
: Updates on new therapies for viral hepatitis, autoimmune liver diseases, and the expanding array of treatments for Inflammatory Bowel Disorders (IBD) Essential Features for Clinicians Visual & Practical Aids : The text includes over 1,100 full-color illustrations and more than 20 procedural videos accessible via the eBook. Decision Support
: Provides quick-reference algorithms to summarize clinical decision-making and practical patient management. Comprehensive Scope : From basic science like the enteric microbiota
to advanced endoscopic procedures like balloon dilatation and stent placement. Publication Details Release Date : December 10, 2025.
: Available as a two-volume hardcover set or as an enhanced eBook through platforms like Page Count : Approximately 2,560 pages or the specific updates regarding IBD treatments in this edition?
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
It seems you’re asking for a piece based on Gastrointestinal and Liver Disease (likely Sleisenger and Fordtran’s), 12th edition, but focused on lifestyle and entertainment—a somewhat unusual angle for a medical textbook.
Below is a short, creative, and informative “lifestyle and entertainment” feature piece written as if it were a magazine section inspired by that authoritative text. It translates key GI/liver health concepts into everyday habits, diet, social drinking, travel, and even “gut-friendly” leisure.
The biggest name change in hepatology history is covered in depth. The term NAFLD is out; MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) is in. The 12th edition is the first major textbook to fully integrate the new nomenclature and the revised treatment pathways involving GLP-1 agonists (like semaglutide) specifically for liver fibrosis.
Yes, but with a nuance. The S Gastrointestinal and Liver Disease 12th Edition is not just a marketing gimmick. It is legitimately "hot" because the field of GI has undergone a paradigm shift. What you learned three years ago about hepatitis, polyps, and IBD is now outdated.
If you are a general practitioner, you can survive with online summaries. But if you are a GI specialist, a fellow, or a hepatologist, this edition is mandatory. The "hot" label refers to the timeliness of the information—it is currently the most accurate, evidence-based text available for the digestive diseases we see this week.
Final Recommendation: Buy the hardcover + digital bundle. Use the digital version for video reference during procedures, and keep the "hot" print edition on your desk for the high-yield board review tables. Do not wait for the 13th edition (likely 2027). In gastroenterology, three years is a lifetime. Get the 12th edition while it is hot.
Disclaimer: Prices and availability subject to change. Always consult the latest clinical guidelines before treating patients.
The 12th edition of Sleisenger and Fordtran’s Gastrointestinal and Liver Disease marks a significant milestone in medical literature, arriving at a time when gastroenterology and hepatology are being reshaped by artificial intelligence, molecular precision, and major shifts in disease nomenclature. Released in late 2025, this two-volume set remains the "gold standard" for clinicians, providing the most current evidence-based pathways for the diagnosis and management of digestive and hepatic disorders. Hot Topics and Major Updates in the 12th Edition
The latest edition introduces critical updates that reflect the fast-paced evolution of the field over the last few years.
The Transition from NAFLD to MASLD: One of the most significant changes is the comprehensive integration of the new nomenclature for fatty liver disease. The text moves away from "Non-Alcoholic Fatty Liver Disease" (NAFLD) to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), reflecting a more precise, non-stigmatizing, and metabolism-centric understanding of the condition.
AI in Endoscopy: The 12th edition highlights the clinical implementation of Artificial Intelligence (AI) for the improved detection of gastrointestinal cancers and polyps during routine colonoscopies.
COVID-19 and the GI Tract: A dedicated new chapter explores the Gastrointestinal and Hepatic Manifestations of Coronavirus Infection, providing a definitive look at the long-term impacts of the pandemic on digestive health.
Novel Therapeutics in IBD: The text has been expanded to include the latest biological agents and novel small molecules that have revolutionized the treatment of Inflammatory Bowel Disease (IBD), including subcutaneous formulations like infliximab.
Advanced Hepatology: Updates include the latest on viral hepatitis (HBV/HCV), autoimmune liver diseases, and the management of complications in cirrhosis, such as portal hypertension and hepatic encephalopathy. Key Features and New Editorial Leadership
This edition is guided by a new generation of leaders: Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox. Their vision brings several practical improvements:
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
The 12th edition of Sleisenger and Fordtran’s Gastrointestinal and Liver Disease
(published in late 2025/early 2026) remains the definitive clinical reference for gastroenterology. While it is a high-level medical textbook rather than "lifestyle and entertainment" in the traditional sense, it heavily incorporates lifestyle management and biopsychosocial factors into modern patient care. Lifestyle and Patient-Centered Content
The 12th edition expands on non-pharmacological management, focusing on how a patient's daily life and mental health intersect with digestive health:
Nutrition and Diet: Dedicated sections cover nutritional principles, assessment, and the management of malnourished patients. You can find these clinical guidelines in the digital version on ClinicalKey.
Biopsychosocial Issues: This edition features a new or expanded section on psychosocial aspects, recognizing that many GI symptoms reflect underlying psychological stress rather than just physical disease.
Obesity Management: There is extensive coverage of obesity, including both surgical and endoscopic treatments, emphasizing the role of lifestyle modification in long-term success.
Complementary and Integrative Medicine: Part XII of the textbook specifically addresses complementary therapies and palliative care for advanced diseases. New Features in the 12th Edition
The latest update introduces several cutting-edge topics that impact clinical practice:
AI in Endoscopy: New discussions on using artificial intelligence for better detection of GI cancers.
COVID-19 Manifestations: A brand-new chapter detailing the gastrointestinal and hepatic manifestations of Coronavirus. This and other summary areas are highlighted by experts at Dr.Oracle.
Metabolic Liver Disease: Updated terminology and management for MASLD (Metabolic dysfunction-associated steatotic liver disease), formerly known as NAFLD.
Cancer Immunotherapy: New chapters on enterocolitis and hepatitis induced by modern cancer treatments. Where to Access
Purchase: The hardcover 2-volume set is available at major retailers like Amazon.com and directly from the publisher Elsevier. s gastrointestinal and liver disease 12th edition hot
Digital/E-Book: An enhanced digital version is available through VitalSource, which includes procedural videos and search tools.
Academic Access: Faculty and students may request a copy for review via the Elsevier Inspection Copy program.
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
The official publisher does not offer a free paper or complete PDF copy of
Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 12th Edition .
To read or reference this comprehensive clinical masterwork legally, you can utilize the following resources: 📖 Official Access Options
Official Purchase: You can secure the two-volume 12th Edition hard copy or eBook directly from the Elsevier Store.
Institutional Access: If you are a student, fellow, or practicing physician, check your university or hospital library's digital access portal. Many medical libraries provide full-text digital access to Elsevier publications via platforms like ClinicalKey or ScienceDirect.
Study & Assessment Companion: If you are preparing for GI boards or seeking targeted practice questions, Elsevier has released the companion book Sleisenger and Fordtran's Gastrointestinal and Liver Disease Review and Assessment, 12th Edition. 🔍 Educational Previews and Medical Reviews
If you need a paper that assesses the content, clinical importance, or structure of this textbook series, look into these published medical reviews:
Book Review via Gastroenterology Journal: Read an expert summary highlighting the clinical and educational value of this classic text on the Gastroenterology Journal Website.
Detailed Academic Breakdown: An insightful look into the textbook's structure, covering its comprehensive sections from cellular biology to clinical therapies, is available on SciSpace.
Previous Editions and Archives: Older public domain materials and indexed metadata associated with the textbook can be referenced through the Internet Archive. 💡 Core Highlights of the 12th Edition:
Edited by a new generation of leaders: Raymond T. Chung, David T. Rubin, and Mel Wilcox.
Contains expanded coverage on emerging topics including AI in endoscopy, COVID-19 gastrointestinal manifestations, and updated liver disease therapeutics.
Spans over 2,500 pages of advanced pathophysiology, diagnosis, and management guidelines.
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
Review: Sleisenger and Fordtran’s Gastrointestinal and Liver Disease 12th Edition
For over 50 years, Sleisenger and Fordtran’s Gastrointestinal and Liver Disease has been the gold standard for medical professionals in the field. The newly released 12th Edition continues this legacy, offering a comprehensive, two-volume masterwork that covers the latest advancements in pathophysiology, diagnosis, and patient management. Key Features of the 12th Edition
This edition welcomes a new senior editorial team—Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox—and introduces significant updates to reflect the rapidly evolving landscape of GI and hepatology.
New Content Chapters: Covers emerging areas such as the gastrointestinal and hepatic manifestations of COVID-19, and a dedicated section on neoplasia involving multiple organs.
AI and Modern Technology: Includes expanded discussions on using Artificial Intelligence (AI) in endoscopy for improved cancer detection.
Updated Disease Management: Provides the latest evidence-based guidance on metabolic dysfunction-associated steatotic liver disease (MASLD), eosinophilic disorders, and new treatments for viral hepatitis and inflammatory bowel disorders.
Visual and Practical Aids: Features more than 1,100 full-color illustrations and quick-reference algorithms to streamline clinical decision-making.
Multimedia Integration: The purchase includes an eBook version and access to over 20 videos of endoscopic procedures. Why Choose This Edition?
According to medical professionals on platforms like Amazon, the text is praised for its unparalleled depth, though some readers note that its comprehensive nature requires significant time to digest for exam preparation. It is an essential resource for: Practicing gastroenterologists and hepatologists. Fellows and residents preparing for board exams. Medical students seeking a definitive reference. Pricing and Availability
The 12th Edition was officially published in December 2025. It is currently available at several major retailers: Amazon India: ₹20,750 DNAMART: ₹20,999 Elsevier Health: Directly from the publisher
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more shop.elsevier.comhttps://shop.elsevier.com
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
If you are studying for Boards (GI Boards or ABIM with GI focus):
The 12th Edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease
is scheduled for release in December 2025. This updated two-volume masterwork is led by a new senior editorial team consisting of Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox. Key Content Updates & New Chapters
The latest edition introduces several new chapters and sections to address emerging clinical challenges:
Gastrointestinal and Hepatic Manifestations of Coronavirus Infection: A dedicated chapter covering the impact of COVID-19 on the GI tract and liver.
Enterocolitis and Hepatitis Induced by Cancer Immunotherapy: Addressing complications from modern cancer treatments.
Neoplasia Involving Multiple Organs: A new section focusing on multi-organ neoplastic processes.
AI in Endoscopy: Coverage of artificial intelligence applications for improved detection of GI cancers.
MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease): Expanded discussion on what was formerly known as non-alcoholic fatty liver disease (NAFLD). Core Table of Contents Structure
The textbook is organized into logical sections covering the full spectrum of gastroenterology and hepatology:
Part I: Biology of the Gastrointestinal Tract: Includes cellular growth, mucosal immunology, and the enteric microbiota.
Part II: Nutrition in Gastroenterology: Covers obesity, surgical/endoscopic treatments, and food allergies.
Part III: Symptoms and Signs: Detailed guides on abdominal pain, dyspepsia, diarrhea, and jaundice.
Part IV: Processes Involving Multiple Organs: Includes manifestations of systemic diseases and preparation for GI endoscopy.
Organ-Specific Sections: Comprehensive parts dedicated to the Esophagus (Part VI), Stomach/Duodenum (Part VII), Pancreas (Part VIII), Biliary Tract (Part IX), and Liver (Part X). Features & Enhanced Learning Tools
Visual Aids: Over 1,100 full-color illustrations and numerous quick-reference algorithms to summarize clinical decision-making.
Multimedia: Access to more than 20 procedural videos demonstrating endoscopic techniques.
Expert Consult eBook: Most purchases include an enhanced eBook version for global search and offline access across devices.
This edition is currently available for pre-order at major retailers like Amazon, Elsevier Health, and Barnes & Noble.
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
Sleisenger and Fordtran's Gastrointestinal and Liver Disease Disclaimer: Prices and availability subject to change
The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease represents a major milestone in clinical gastroenterology. This new release integrates cutting-edge molecular biology with practical bedside management, making it an essential resource for practitioners and fellows alike. What’s New in the 12th Edition?
The latest edition focuses heavily on the "biopsychosocial" model of care and the rapid evolution of therapeutic endoscopy.
Precision Medicine: Expanded coverage of genetic testing and personalized biological therapies.
Gut Microbiome: New insights into how bacterial ecosystems influence systemic health and disease.
Advanced Imaging: Updates on "Cold" EMR, AI-assisted colonoscopies, and non-invasive liver elastography.
COVID-19 Context: Comprehensive data on the long-term GI and hepatic manifestations of the pandemic. Key Clinical Pillars 1. Inflammatory Bowel Disease (IBD)
The text moves beyond simple symptom management. It emphasizes "Treat-to-Target" strategies, focusing on mucosal healing rather than just clinical remission. 2. Hepatology and NASH/MASH
With the renaming of Fatty Liver Disease to MASH, the 12th edition provides the most current nomenclature and pharmacological pipelines for treating metabolic liver dysfunction. 3. Functional Disorders
There is a renewed focus on the brain-gut axis. The edition highlights neuromodulators and behavioral therapies as primary tools for IBS and functional dyspepsia. Why This Edition Matters Now
Evidence-Based: Thousands of new citations from 2020–2024.
Visual Learning: Over 1,000 high-definition pathology slides and endoscopic photos.
Expert Authorship: Contributions from hundreds of global leaders in the field.
💡 Clinical Pearl: The 12th edition highlights that early intervention in chronic liver disease can reverse fibrosis—a shift from the "permanent damage" mindset of older texts.
To help you tailor this post for your specific audience, could you tell me:
Who is your primary reader? (Medical students, practicing GIs, or informed patients?)
What is the desired length? (A short "What's New" summary or a deep-dive review?)
I can adjust the tone from academic to conversational based on your needs.
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
What’s New in GI? A Deep Dive into Sleisenger and Fordtran’s 12th Edition For over half a century,
Sleisenger and Fordtran’s Gastrointestinal and Liver Disease
has been the "gold standard" for anyone treating digestive and hepatic conditions. With the release of the 12th Edition
(December 2025), this two-volume masterwork continues its legacy while pivoting toward the future of personalized medicine and digital health.
If you’re deciding whether to upgrade your clinical library, here are the "hottest" updates in this latest release. 1. The Rise of AI in Endoscopy One of the most buzzworthy additions is the focus on Artificial Intelligence (AI)
in the endoscopy suite. The 12th edition details how AI is being used to improve the detection of GI cancers and polyps, helping clinicians move toward higher precision during procedures. 2. Renaming a Global Health Crisis: From NAFLD to MASLD
Reflecting the latest international consensus, the textbook has fully adopted the term
(Metabolic dysfunction-associated steatotic liver disease), formerly known as NAFLD. This shift isn't just about semantics; it represents a more accurate understanding of the metabolic drivers behind liver disease—a core focus of the updated liver sections. 3. Cutting-Edge New Chapters
Modern medicine moves fast, and the editors (Drs. Chung, Rubin, and Wilcox) have added critical chapters to address contemporary challenges: COVID-19 Manifestations:
Dedicated coverage on how the coronavirus affects both the GI tract and the liver. Cancer Immunotherapy Side Effects: New insights into Enterocolitis and Hepatitis
induced by immunotherapy, a growing concern for oncologists and gastroenterologists alike. Neoplasia Involving Multiple Organs:
A new section exploring complex tumor behaviors across organ systems. 4. Therapeutic Breakthroughs: IBD & Viral Hepatitis
The 12th edition dives deep into the "explosion" of new treatments for Inflammatory Bowel Disease (IBD)
. From novel biologics to small molecules, the updated text serves as a roadmap for managing refractory cases. Similarly, you’ll find the latest protocols for Chronic Hepatitis B and C
, including strategies for viral eradication and long-term management. 5. Enhanced Digital Experience Whether you prefer the 2-volume hardcover set Expert Consult eBook , the 12th edition is designed for speed. Clinical Algorithms:
Dozens of updated decision-making flows for quick bedside reference. Procedural Videos:
Over 20 high-quality videos demonstrating everything from stent placement to balloon dilatation. Why It’s Still the "GI Bible"
Despite the rise of online Wikis and quick-search databases, Sleisenger and Fordtran remains essential because it provides
. It bridges the gap between basic pathophysiology and the messy, complex reality of clinical practice. Ready to update your practice? You can find the 12th edition at major retailers like Elsevier Health Barnes & Noble mentioned in this edition?
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
Maintaining a Healthy Gut: Lifestyle Tips for Gastrointestinal and Liver Disease Prevention
As we navigate our busy lives, it's easy to neglect our gut health. However, a healthy gastrointestinal (GI) tract and liver are essential for overall well-being. The 12th edition of a leading medical textbook on gastrointestinal and liver disease emphasizes the importance of lifestyle modifications in preventing and managing GI disorders.
Diet and Nutrition
A balanced diet rich in fiber, fruits, vegetables, and whole grains can help promote digestive health. Foods high in fiber, such as broccoli, carrots, and apples, can help regulate bowel movements and prevent constipation. A diet low in processed meats, sugar, and saturated fats can also reduce the risk of GI disorders.
Stay Hydrated
Adequate hydration is essential for maintaining healthy digestion and preventing constipation. Aim to drink at least eight glasses of water a day, and limit sugary drinks that can disrupt gut health.
Exercise and Stress Management
Regular exercise can help stimulate digestion and improve gut motility. Stress management techniques, such as meditation, yoga, or deep breathing, can also help alleviate symptoms of irritable bowel syndrome (IBS) and other GI disorders.
Limiting Substance Use
Excessive alcohol consumption can lead to liver damage and increase the risk of GI disorders. Quitting smoking and limiting caffeine intake can also help promote gut health.
Entertainment and Relaxation
While it may not seem directly related to gut health, engaging in enjoyable activities and relaxation techniques can help reduce stress and promote overall well-being. Whether it's reading a book, listening to music, or practicing a hobby, making time for relaxation and entertainment can have a positive impact on digestive health. If you are a gastroenterologist
Tips for a Healthy Gut
By incorporating these lifestyle tips into your daily routine, you can help promote a healthy gut and reduce the risk of gastrointestinal and liver disease.
No specific mathematical formulas are included in this response; however, in case of any mathematical concepts in gastrointestinal and liver disease, these will be denoted using $$ syntax without newlines.
Report: Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 12th Edition
Introduction
Sleisenger and Fordtran's Gastrointestinal and Liver Disease is a comprehensive textbook that has been a benchmark in the field of gastroenterology and hepatology for over 50 years. The 12th edition of this renowned textbook continues to provide in-depth coverage of the latest advances in the diagnosis, treatment, and management of gastrointestinal and liver diseases.
Key Features of the 12th Edition
The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease has been thoroughly updated and revised to reflect the latest scientific and clinical knowledge in the field. Some of the key features of this edition include:
Major Updates and Highlights
Some of the major updates and highlights of the 12th edition include:
Target Audience
The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease is an essential resource for:
Conclusion
The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease is a comprehensive textbook that provides a detailed overview of the diagnosis, treatment, and management of gastrointestinal and liver diseases. The textbook is an essential resource for gastroenterologists, hepatologists, internal medicine physicians, and trainees in these fields.
The 12th Edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease
was released on December 10, 2025. This version introduces a new senior editorial team consisting of Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox. Key Updates & New Features
The latest edition contains significant updates to reflect the modern landscape of gastroenterology and hepatology:
New Chapters: Features dedicated sections on Gastrointestinal and Hepatic Manifestations of Coronavirus Infection (COVID-19) and Enterocolitis and Hepatitis Induced by Cancer Immunotherapy.
Technological Advances: Expanded coverage on the use of Artificial Intelligence (AI) in endoscopy for improved detection of GI cancers.
Renamed Conditions: Includes updated discussions on MASLD (Metabolic dysfunction-associated steatotic liver disease), formerly known as non-alcoholic fatty liver disease (NAFLD).
Expanded Treatments: New sections on treatments for viral hepatitis, autoimmune liver diseases, and an array of new therapies for inflammatory bowel disorders (IBD).
Liver Disease Focus: Four new chapters specifically covering coagulation, non-invasive assessment of fibrosis and cirrhosis, vascular diseases of the liver, and nutrition in liver disease. Reference & Study Tools
Visual Aids: Over 1,100 full-color illustrations and clinically practicable algorithms to assist in quick decision-making.
Digital Content: Includes more than 20 videos of endoscopic procedures and digital downloads of figures for use in presentations.
Review Book: A companion volume, Sleisenger and Fordtran's Gastrointestinal and Liver Disease Review and Assessment, 12th Edition, is available for board preparation and self-assessment. Where to Find It
The two-volume set can be purchased through medical retailers and publishers: Elsevier Shop Amazon VitalSource (for digital/eTextbook versions)
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
Sleisenger and Fordtran's Gastrointestinal and Liver Disease - 2 Volume Set - 12th Edition | Elsevier Shop
12th edition Sleisenger and Fordtran's Gastrointestinal and Liver Disease was released on December 10, 2025
This gold-standard medical text has been updated with a new senior editorial team consisting of Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox Hot Topics & New Features
The latest edition incorporates significant updates to clinical practice, including: Novel Conditions : New chapters specifically dedicated to gastrointestinal/hepatic manifestations and Immunotherapy-Induced enterocolitis and hepatitis. AI in Medicine : Expanded coverage of AI-powered endoscopy for enhanced cancer detection. Liver Disease : Updated terminology and clinical guidance for
(Metabolic dysfunction-Associated Steatotic Liver Disease, formerly NAFLD). Advanced Treatments : Latest advances in treatments for Viral Hepatitis Autoimmune Liver Diseases Inflammatory Bowel Disorders Digital Resources : Access to over of endoscopic procedures and monthly online updates. US Elsevier Health Book Specifications
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
Pathophysiology, Diagnosis, Management * Editors: Raymond T. Chung, David T. Rubin, Mel Wilcox. Published: December 10, 2025.
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
You're looking for information about the 12th edition of "Sleisenger and Fordtran's Gastrointestinal and Liver Disease". This is a well-known and highly respected textbook in the field of gastroenterology.
Here are some details about the book:
Title: Sleisenger and Fordtran's Gastrointestinal and Liver Disease Edition: 12th Edition Publishers: Elsevier Publication Date: 2021
This comprehensive textbook covers a wide range of topics related to gastrointestinal and liver diseases, including:
The 12th edition of this textbook features:
Key Features:
Target Audience:
Is there something specific you'd like to know about this textbook or a particular topic in gastroenterology? I'll do my best to help!
Headline: Hot Off the Press: Why the 12th Edition of “Sleisenger” is the Hottest Ticket in GI Medicine
Subheadline: The gold standard just got a serious upgrade. What you need to know about the latest edition of the bible of gastroenterology.
If you are a gastroenterologist, hepatologist, or GI fellow, you know the name. For decades, Sleisenger and Fordtran’s Gastrointestinal and Liver Disease has been the brick on every specialist’s desk—the go-to for pathophysiology, clinical insights, and evidence-based management.
Well, turn up the air conditioning, because the 12th Edition is officially hot.
This isn't just a minor refresh. In a field moving as fast as immunology, microbiome science, and targeted cancer therapy, the 11th edition was starting to feel like last season’s jersey. The new 12th edition has arrived, and it is burning with updates.
Here is why this release is generating serious heat in the medical community.
The 12th edition (published recently, following the 2016 11th edition) is highly anticipated and widely used because it bridges the gap between rapid scientific discovery and clinical practice. It is considered the "gold standard" reference for gastroenterologists, hepatologists, and trainees.